HighTower Advisors’s Telomir Pharmaceuticals TELO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-43,000
Closed -$139K 3735
2025
Q1
$139K Buy
+43,000
New +$139K ﹤0.01% 3262